Advanced Filters
noise

polycystic-ovarian-syndrome Clinical Trials

A listing of polycystic-ovarian-syndrome medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 99 clinical trials
T Terhi Piltonen, Professor

PEPPI Study: Identification of Women at Risk for Placental Dysfunction

The main purpose of this study is to evaluate Fetal Medicine Foundation's pre-eclampsia risk calculator using maternal characteristics, first trimester serum placental growth factor (PlGF) and mean arterial pressure (MAP) in a Finnish general population. Condition or disease: pre-eclampsia, intrauterine growth restriction, polycystic ovary syndrome

years of age All Phase N/A
I Iwona Gawron, Ph.D., M.D.

Adipokines in Polycystic Ovary Syndrome

The aim of the study is to compare the concentrations of leptin, resistin, and omentin-1 in women across three research groups: those with polycystic ovary syndrome without insulin resistance, those with polycystic ovary syndrome with insulin resistance, and women without polycystic ovary syndrome.

18 - 45 years of age Female Phase N/A
I Iwona M. Gawron, Ph.D.

Pro- and Anti-inflammatory Cytokines in PCOS

The study will involve measurements and comparisons of the concentrations of pro-inflammatory cytokines: IL-6, TNF-α, IL-18, as well as anti-inflammatory cytokine IL-4 in women with polycystic ovary syndrome (PCOS) and insulin resistance, women with polycystic ovary syndrome without carbohydrate metabolism disorders, and women without PCOS (control group).

18 - 45 years of age Female Phase N/A

Functional Proteins in PCOS

The concentration of functional proteins: kisspeptin, ghrelin, zonulin will be measured and compared in women with polycystic ovary syndrome (PCOS) and insulin resistance (IR), in women with PCOS without IR, and in women without PCOS.

18 - 45 years of age Female Phase N/A
X Xu Shan Gao, Drs

Gut- and Vaginal Microbiome Composition in Association With PCOS

Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects up to 10% of the reproductive-aged women worldwide. The etiology is still unknown and treatment therefore remains symptomatic. Studies indicate a possible role of the gut microbiome in the pathology of PCOS. PCOS women have a disturbed gut microbiome, with …

18 - 45 years of age Female Phase N/A
D Dorte Glintborg, MD PhD

Characterization of a Prospective Cohort of Women With PCOS

Polycystic ovary syndrome (PCOS) is a common endocrine disorder in premenopausal women. PCOS is characterized by increase levels of testosterone, unwanted hair growth, adiposity, irregular menstrual cycle, and infertility. PCOS is associated with diabetes mellitus and cardiovascular diseases. Women with PCOS are reported to have increased levels of stress hormones, …

18 - 45 years of age Female Phase N/A
M Michael W O'Reilly, FRCPI PhD

REFUEL PCOS Study 1

Polycystic Ovary Syndrome (PCOS) affects 10% of all women, and it usually co-exists with high levels of male pattern hormones (also termed androgens). Women with PCOS are at increased risk of metabolic complications such as diabetes, non-alcoholic fatty liver disease, high blood pressure and heart disease. However, very little is …

18 - 50 years of age Female Phase N/A
R Ralf Dittrich, Prof

Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study

The purpose of the study is to validate recently identified biomarkers for the identification of PCOS in adolecent and young adult women.

15 - 25 years of age Female Phase N/A
A Anikó Gál, PhD

Polycystic Ovary Syndrome, Mitochondrial Dysfunction, Obesity, Insulin Resistance Infertility (POMODORI) Cohort

Enrolling of 150 female patients of fertile age diagnosed with PCOS, insulin resistance, infertility, or mitochondrial disease, and the same number of age- and sex-matched controls are planned. During the research biomarkers already with mitochondrial dysfunction in the scientific literature and common mtDNA abnormalities (deletions, point mutations, copy number changes, …

20 - 45 years of age Female Phase N/A
E Elena Fernández Durán

Body Fat as Determinant of Female Gonadal Dysfunction

Reproduction requires from women enough energy depots to warrant an adequate nutritional supply to the fetus. Hence, adipose tissue is able to communicate with female hypothalamic-pituitary-ovary axis. The hypothesis of the project is that abnormalities in the quantity (absolute and relative to lean body mass), distribution and/or function of adipose …

18 - 40 years of age Female Phase N/A

Simplify language using AI